[HTML][HTML] Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee… - Nature …, 2019 - pubmed.ncbi.nlm.nih.gov
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
[HTML][HTML] Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee, O Ouari… - Nature …, 2019 - ncbi.nlm.nih.gov
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee… - Nature …, 2019 - econpapers.repec.org
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee, O Ouari… - Nature …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Lung cancer often has a poor prognosis, with
brain metastases a major reason for mortality. We modified lonidamine (LND), an …
brain metastases a major reason for mortality. We modified lonidamine (LND), an …
[PDF][PDF] Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee, O Ouari, M Hardy… - researchgate.net
To compare the antiproliferative effects of LND and Mito-LND, human lung cancer cells were
treated with LND or Mito-LND. Cell proliferation data show the concentration-dependent …
treated with LND or Mito-LND. Cell proliferation data show the concentration-dependent …
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis.
G Cheng, Q Zhang, J Pan, Y Lee… - Nature …, 2019 - search.ebscohost.com
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
[PDF][PDF] Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee, O Ouari, M Hardy… - icr-amu.cnrs.fr
To compare the antiproliferative effects of LND and Mito-LND, human lung cancer cells were
treated with LND or Mito-LND. Cell proliferation data show the concentration-dependent …
treated with LND or Mito-LND. Cell proliferation data show the concentration-dependent …
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee, O Ouari… - Nature …, 2019 - hal.science
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
G Cheng, Q Zhang, J Pan, Y Lee… - Nature …, 2019 - ui.adsabs.harvard.edu
Lung cancer often has a poor prognosis, with brain metastases a major reason for mortality.
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …
We modified lonidamine (LND), an antiglycolytic drug with limited efficacy, to mitochondria …